跳转至内容
Merck
CN
  • Direct neuronal conversion of microglia/macrophages reinstates neurological function after stroke.

Direct neuronal conversion of microglia/macrophages reinstates neurological function after stroke.

Proceedings of the National Academy of Sciences of the United States of America (2023-10-09)
Takashi Irie, Taito Matsuda, Yoshinori Hayashi, Kanae Matsuda-Ito, Akihide Kamiya, Takahiro Masuda, Marco Prinz, Noriko Isobe, Jun-Ichi Kira, Kinichi Nakashima
摘要

Although generating new neurons in the ischemic injured brain would be an ideal approach to replenish the lost neurons for repairing the damage, the adult mammalian brain retains only limited neurogenic capability. Here, we show that direct conversion of microglia/macrophages into neurons in the brain has great potential as a therapeutic strategy for ischemic brain injury. After transient middle cerebral artery occlusion in adult mice, microglia/macrophages converge at the lesion core of the striatum, where neuronal loss is prominent. Targeted expression of a neurogenic transcription factor, NeuroD1, in microglia/macrophages in the injured striatum enables their conversion into induced neuronal cells that functionally integrate into the existing neuronal circuits. Furthermore, NeuroD1-mediated induced neuronal cell generation significantly improves neurological function in the mouse stroke model, and ablation of these cells abolishes the gained functional recovery. Our findings thus demonstrate that neuronal conversion contributes directly to functional recovery after stroke.

材料
货号
品牌
产品描述

Sigma-Aldrich
泰莫西芬, ≥99%
Sigma-Aldrich
抗NeuN抗体,克隆A60, clone A60, Chemicon®, from mouse
Sigma-Aldrich
抗胶质纤维酸性蛋白抗体, Chemicon®, from chicken
Sigma-Aldrich
抗胶质纤维酸性蛋白 兔抗, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
抗-MAP2 (2a+2b)抗体,小鼠单克隆 小鼠抗, clone AP-20, ascites fluid
Sigma-Aldrich
抗-CUX1抗体,a.a.861, from rabbit, purified by affinity chromatography